The optimal combination identified was MCP 3 PD, digit flexor GS and ACPA positivity (Table 4), with the proportion of RA vs non-RA patients correctly identified in our cohort being 80.4%. This evidence concerns the gene PRTN3 and rheumatoid arthritis.